Search results for " pentoxifylline"

showing 2 items of 2 documents

Antioxidants: Role in the prevention and treatment of bronchopulmonary dysplasia

2022

Bronchopulmonary dysplasia (BPD) is one of the major causes of chronic respiratory diseases among infants. Both pharmacological and nonpharmacological approaches have been proposed for its management. Since oxidative stress is known to play a pivotal role in the pathogenesis of BPD, it is reasonable to consider the potential of antioxidant strategies in the prevention and treatment of this condition. Indeed, antioxidants can prevent or inhibit substrate oxidation. Some studies have evaluated the efficacy of the exogenous administration of vitamins and micronutrients in reducing the propagation of free radicals through their scavenging capacity. Nonetheless, encouraging preclinical results d…

Pulmonary and Respiratory MedicineInfant NewbornInfantVitaminsBronchopulmonary dysplasiaAntioxidantsVitaminOxidative StressSeleniumZincPediatrics Perinatology and Child HealthHumansBronchopulmonary dysplasia Melatonin Pentoxifylline Selenium Vitamins ZincPentoxifyllineVitamin AInfant PrematureMelatonin
researchProduct

pentoxifylline inhibits vgamma9/vdelta2 t lymphocyte activation of patients with active behçet's disease

2007

The aim ofthis study is to evaluate the in vitro effect ofpentoxifylline (PTX) on T Vy9No21ymphocyte function in Beheet's disease (DO). We investigated the effect of PTX on Vy9No2 T cell expansion and expression of TNFRII receptor and perforin content before and after PTX addition by means of FACS analysis lymphocyte cultures from patients with active and inactive DO and healthy subjects. The addition of PTX at a concentration of 1 mg/ml determined a significant inhibition of cell expansion, a down regulation of TNF receptor expression and inhibited the PMA-induced degranulation of perforin. Taken together these data indicate that PTX is capable of interfering with Vy9No2 T cell function in…

pentoxifyllineBehcet s diseaseVy9/Vc>2 T lymphocyteBehcet s disease Vy9/Vc>2 T lymphocytes perforin pentoxifyllineperforin
researchProduct